Aripiprazole: Does partial dopaminergic agonism translate into clinical benefits?

M. Lynn Crismon, Anthony DeLeon, Alexander L. Miller

Research output: Contribution to journal › Editorial › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Aripiprazole: Does partial dopaminergic agonism translate into clinical benefits?'. Together they form a unique fingerprint.